COMMUNIQUÉS West-GlobeNewswire

Novo Nordisk A/S – Share repurchase programme
29/07/2019
Novo Nordisk A/S – Share repurchase programme Bagsværd, Denmark, 29 July 2019 – On 7 May 2019, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European [...]
FDA Accepts IND Application for Cerecor’s Investigational Drug CERC-802 for the treatment of MPI-CDG
29/07/2019
ROCKVILLE, Md., July 29, 2019 (GLOBE NEWSWIRE) -- Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on becoming a leader in development and commercialization of treatments for rare and orphan diseases in [...]
Union Terminal’s Modern Technology Enables a World-Class Experience for Cincinnati Museum Center Visitors
29/07/2019
CINCINNATI, July 29, 2019 (GLOBE NEWSWIRE) -- “Modernization” is not a new concept for 1933-Cincinnati-icon, Union Terminal. From the Art Deco architecture characteristic of the 1920s and -30s to the gravity-defying [...]
Arrayit Corporation Announces Global Expansion of Finger Stick Health and Wellness Testing Services
29/07/2019
Food Sensitivity Testing Now Available in the Philippines Sunnyvale, July 29, 2019 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC ), a life sciences and personalized medicine company, announces expansion of its [...]
Online Muslim Mental Health company TherapyLine that aims to Normalize Mental Health services in the Muslim world launches in the UK, Australia and New Zealand this week.
29/07/2019
LONDON, July 29, 2019 (GLOBE NEWSWIRE) -- TherapyLine, the online mobile mental health company for Muslims, launches in three new markets today, UK, Australia and New Zealand, as part of a larger plan to provide [...]
Share buy-back week 30/2019
29/07/2019
Announcement 29 July 2019 Coloplast – transactions in connection with share buy-back programme As mentioned in Announcement No. 2/2019 Coloplast has initiated the second part of the share buy-back programme totalling up [...]
Zealand Pharma announces change in corporate management
29/07/2019
Company announcement – No. 24 / 2019 Zealand Pharma announces change in corporate management Copenhagen, Denmark, July 29, 2019 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78) announces that Andrew [...]
GENFIT: FDA and EMA Grant GENFIT’s Elafibranor Orphan Drug Designation for Primary Biliary Cholangitis (PBC)
29/07/2019
FDA and EMA Grant GENFIT’s Elafibranor Orphan Drug Designation for Primary Biliary Cholangitis (PBC) Lille (France), Cambridge (Massachusetts, United States), July 29, 2019 – GENFIT (Nasdaq and Euronext: GNFT) , a late- [...]
GENFIT : La FDA et l’EMA accordent la désignation d’Orphan Drug à elafibranor pour le traitement de la Cholangite Biliaire Primitive (PBC)
29/07/2019
La FDA et l’EMA accordent la désignation d’Orphan Drug à elafibranor pour le traitement de la Cholangite Biliaire Primitive (PBC) Lille (France), Cambridge (Massachusetts, États-Unis), le 29 juillet 2019 – GENFIT ( [...]
Sanofi delivered solid growth in Q2 2019
29/07/2019
Paris, July 29, 2019 Sanofi delivered solid growth in Q2 2019 Q2 2019 Change Change at CER H1 2019 Change Change at CER IFRS net sales reported €8,628m +5.5% +3.9% €17,019m +5.9% +4.1% IFRS net income reported -€87m - [...]
Sanofi affiche une croissance solide au deuxième trimestre 2019
29/07/2019
Paris, le 29 juillet 2019 Sanofi affiche une croissance solide au deuxième trimestre 2019 T2 2019 Variation Variation à TCC S1 2019 Variation Variation à TCC Chiffre d’affaires net IFRS publié €8 628m +5,5% +3,9% €17 [...]
Novartis provides update on Phase III PARAGON-HF trial in heart failure patients with preserved ejection fraction (HFpEF)
29/07/2019
PARAGON study narrowly misses statistical significance on the primary endpoint; overall safety profile confirmed Totality of evidence suggests potential clinically important benefit; results will be presented in [...]
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
26/07/2019
WALTHAM, Mass. and CRESTWOOD, Ky., July 26, 2019 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals Inc., (Nasdaq:APLS) a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to [...]
Lexicon Pharmaceuticals Provides Preliminary Update for Zynquista™ (Sotagliflozin) Type 2 Diabetes Phase 3 Program
26/07/2019
Sanofi Provides Disputed Termination Notice THE WOODLANDS, Texas,, July 26, 2019 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), received preliminary topline results from Sanofi for three Phase 3 [...]
Diversicare to Announce Second Quarter 2019 Financial Results on Thursday, August 1, 2019
26/07/2019
BRENTWOOD, Tenn., July 26, 2019 (GLOBE NEWSWIRE) -- Diversicare Healthcare Services, Inc. (NASDAQ:DVCR) today announced that it is scheduled to report financial results for its second quarter ended June 30, 2019, on [...]
Sanofi : Sanofi provides update on ZynquistaTM (sotagliflozin) type 2 diabetes Phase 3 program and collaboration with Lexicon
26/07/2019
Sanofi provides update on Zynquista TM (sotagliflozin) type 2 diabetes Phase 3 program and collaboration with Lexicon PARIS – July 26, 2019 – Sanofi today announced topline results from three Phase 3 trials of Zynquista [...]
Sanofi : Sanofi fournit des informations actualisées sur ZynquistaTM (sotagliflozine) dans le traitement du diabète de type 2 et sa collaboration avec Lexicon
26/07/2019
Sanofi fournit des informations actualisées sur Zynquista TM (sotagliflozine) dans le traitement du diabète de type 2 et sa collaboration avec Lexicon Paris – Le 26 juillet 2019 – Sanofi annonce aujourd’hui les premiers [...]
Alder BioPharmaceuticals® Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
26/07/2019
BOTHELL, Wash., July 26, 2019 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (Nasdaq: ALDR), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, today [...]
priMED Medical Products Appoints Lucas Ethier as Executive Vice President
26/07/2019
Company fortifies its commitment to market growth, product focus and worldwide expansion EDMONTON, Alberta, Canada, July 26, 2019 (GLOBE NEWSWIRE) -- priMED Medical Products Inc. (priMED), a global medical product [...]

Pages